X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/03/11/2844161/0/en/Anaptys-Announces-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com//news-release/2024/02/29/2838079/0/en/Anaptys-to-Present-at-TD-Cowen-s-44th-Annual-Health-Care-Conference-and-2024-AAD-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/01/31/2821240/0/en/Anaptys-to-Present-at-Guggenheim-s-6th-Annual-Biotechnology-Conference.html
https://www.fiercebiotech.com/biotech/anaptys-picks-rival-biogen-autoimmune-asset-centessa
https://www.globenewswire.com//news-release/2023/11/27/2786530/0/en/Anaptys-Expands-Immune-Cell-Modulator-Pipeline-with-Exclusive-License-to-BDCA2-Modulator-Antibody-Portfolio-from-Centessa-Pharmaceuticals.html
https://www.globenewswire.com//news-release/2023/11/07/2775654/0/en/Anaptys-Named-a-BioSpace-2024-Best-Places-to-Work-Winner.html
https://www.globenewswire.com//news-release/2023/11/02/2772847/0/en/Anaptys-Announces-Third-Quarter-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com//news-release/2023/11/01/2771329/0/en/Anaptys-Announces-Participation-in-November-Investor-Conferences.html
https://www.globenewswire.com//news-release/2023/10/11/2758455/0/en/Anaptys-to-Present-Phase-1-Data-on-ANB032-its-BTLA-Agonist-Antibody-at-the-32nd-EADV-Congress.html
https://www.fiercebiotech.com/biotech/chasing-boehringer-anaptys-hits-goal-pivotal-rare-skin-disease-trial-plans-outlicensing
Market Place
Share 
